Literature DB >> 20522710

Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma.

Anna-Maria Strothmeyer1, Dimitrios Papaioannou, Marcus Dühren-von Minden, Marcelo Navarrete, Katja Zirlik, Kristina Heining-Mikesch, Hendrik Veelken.   

Abstract

Active immunization with the idiotype of follicular lymphoma induces tumor-specific immunity. T cells induced in vivo by idiotype vaccination recognize human leukocyte antigen (HLA)--restricted hypervariable but not conserved idiotype peptides. We hypothesized that idiotype-directed T-cell immunity occurs naturally and performed a reverse immunology analysis of idiotype HLA binding in 39 follicular lymphoma patients. For every idiotype, the sum of HLA-A or -B binding scores of the 20 highest-scoring peptides was calculated for all 39 HLA types through the BIMAS algorithm. The idiotype sum score of every patient's lymphoma was compared on the respective patient's HLA type to the mean of the sum scores of the remaining 38 idiotypes. Autologous idiotypes had lower immunogenicity than allogeneic idiotypes. Differential immunogenicity resided predominantly in all 3 complementarity-determining regions rather than in framework peptides. Idiotype immunogenicity was not changed by somatic hypermutation. These findings indicate T cell-mediated immunosurveillance of follicular lymphoma directed specifically against individual idiotype epitopes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20522710     DOI: 10.1182/blood-2010-02-270199

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma.

Authors:  Jooeun Bae; Weihua Song; Robert Smith; John Daley; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

2.  Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes.

Authors:  Jinsheng Weng; Soung-Chul Cha; Satoko Matsueda; Gheath Alatrash; Michael S Popescu; Qing Yi; Jeffrey J Molldrem; Michael Wang; Sattva S Neelapu; Larry W Kwak
Journal:  Clin Cancer Res       Date:  2011-08-03       Impact factor: 12.531

3.  Evidence for idiotype-directed immunosurveillance is restricted to follicular lymphoma and attributable to somatic hypermutation.

Authors:  Dimitrios Papaioannou; Anna-Maria Strothmeyer; Marcus Dühren-von Minden; Andrea Keppler-Hafkemeyer; Katja Zirlik; Kristina Mikesch; Cornelis A M van Bergen; Marcelo A Navarrete; Hendrik Veelken
Journal:  Haematologica       Date:  2015-01-23       Impact factor: 9.941

Review 4.  Trial watch: DNA-based vaccines for oncological indications.

Authors:  Stefano Pierini; Renzo Perales-Linares; Mireia Uribe-Herranz; Jonathan G Pol; Laurence Zitvogel; Guido Kroemer; Andrea Facciabene; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

5.  Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.

Authors:  Jooeun Bae; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi
Journal:  Br J Haematol       Date:  2011-09-09       Impact factor: 6.998

6.  Highly conserved antigenic epitope regions of hemagglutinin and neuraminidase genes between 2009 H1N1 and seasonal H1N1 influenza: vaccine considerations.

Authors:  Ping Huang; Shouyi Yu; Changyou Wu; Lijun Liang
Journal:  J Transl Med       Date:  2013-02-22       Impact factor: 5.531

7.  B-cell lymphomas present immunoglobulin neoantigens.

Authors:  Michael S Khodadoust; Niclas Olsson; Binbin Chen; Brian Sworder; Tanaya Shree; Chih Long Liu; Lichao Zhang; Debra K Czerwinski; Mark M Davis; Ronald Levy; Joshua E Elias; Ash A Alizadeh
Journal:  Blood       Date:  2018-12-13       Impact factor: 25.476

8.  Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens.

Authors:  Michael S Khodadoust; Niclas Olsson; Lisa E Wagar; Ole A W Haabeth; Binbin Chen; Kavya Swaminathan; Keith Rawson; Chih Long Liu; David Steiner; Peder Lund; Samhita Rao; Lichao Zhang; Caleb Marceau; Henning Stehr; Aaron M Newman; Debra K Czerwinski; Victoria E H Carlton; Martin Moorhead; Malek Faham; Holbrook E Kohrt; Jan Carette; Michael R Green; Mark M Davis; Ronald Levy; Joshua E Elias; Ash A Alizadeh
Journal:  Nature       Date:  2017-03-22       Impact factor: 49.962

9.  High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution.

Authors:  Emanuela Carlotti; David Wrench; Guglielmo Rosignoli; Jacek Marzec; Ajanthah Sangaralingam; Lena Hazanov; Miri Michaeli; Simon Hallam; Tracy Chaplin; Sameena Iqbal; Maria Calaminici; Bryan Young; Ramit Mehr; Peter Campbell; Jude Fitzgibbon; John G Gribben
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.